CONCURRENT SESSION – PART 2 (B) - 4:02 – 4:10 pm
Bariatric Medicine Accepted Papers
Metabolic and renal outcomes of empagliflozin in patients with type 2 diabetes mellitus
Speaker
Dr. Ali Alshahrani, MD
CONCURRENT SESSION – PART 2 (B) - 4:02 – 4:10 pm
Dr. Ali Alshahrani, MD